Why Patients Switch to Wegovy & How Much They Save
Wegovy Switching Benefits: Why Make the Change?
Switching to Wegovy from other GLP-1 medications offers distinct clinical and practical advantages. The most compelling reason is Wegovy's superior storage flexibility - maintaining potency for 6 weeks at room temperature compared to Mounjaro's 21-day limit. This makes Wegovy ideal for frequent travellers or those with inconsistent refrigeration access. Additionally, the recent SELECT cardiovascular outcomes trial demonstrated a 20% reduction in major cardiovascular events, positioning Wegovy as the only GLP-1 medication with proven heart health benefits.
Cost considerations also drive switching decisions, particularly when insurance coverage changes or private payment becomes necessary. At EverydayMeds, we've structured our Wegovy pricing to offer significant savings compared to traditional pharmacy channels. Our transparent pricing model eliminates hidden fees and provides clear monthly costs. Many patients report saving £150-300 monthly compared to their previous GLP-1 medication expenses, making long-term weight management financially sustainable.
Wegovy Pricing Structure & Switch Savings Calculator
Our competitive Wegovy pricing starts with the 0.25mg starter dose at £79.99, progressing through 0.5mg at £94.99, 1mg at £99.99, 1.7mg at £139.99, to the 2.4mg maintenance dose at £209.99. New customers apply code FIRST40 at checkout, whilst returning customers use DOSE25 to access these rates. Our Getting Started bundles provide additional convenience - the Intro Duo (0.25mg & 0.5mg) costs £169.99, covering your first two months. The Progress Trio (0.5mg, 1mg & 1.7mg) at £369.99 spans three crucial escalation months, ensuring uninterrupted treatment.
For maintenance therapy, our Ultimate Stability Trio provides three months of 2.4mg doses for £649.99, offering peace of mind with Reliable Supply. We also accommodate patients requiring slower titration with our Gentle Start Trio (0.25mg, 0.25mg, 0.5mg) for £269.99. All pricing includes next-day cold-chain delivery and clinical support from our GPhC #9012878 registered pharmacy team. Bundle pricing emphasises convenience - fewer orders, Reliable Supply continuity, and single delivery logistics rather than individual pen calculations.
Wegovy Clinical Evidence from STEP Trials
The pivotal STEP clinical programme established Wegovy's efficacy profile through rigorous randomised controlled trials. In STEP 1, patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks compared to 2.4% with placebo. STEP 2 specifically evaluated patients with type 2 diabetes, demonstrating 9.6% weight reduction alongside improved glycaemic control.
The STEP 5 trial confirmed sustained weight management, with participants maintaining clinically studied weight loss at two years when continuing treatment. Most significantly, the SELECT cardiovascular outcomes trial (Wilding et al., NEJM, 2021) showed Wegovy reduced major cardiovascular events by 20% in adults with established cardiovascular disease, representing a innovative in weight management medicine with proven heart health benefits.
How Wegovy Works: GLP-1 Mechanism Explained
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural incretin hormone. This prescription-only medicine targets specific brain regions controlling appetite and food intake, reducing hunger signals and promoting satiety after smaller meals. The medication works by slowing gastric emptying, meaning food remains in your stomach longer, creating sustained fullness. Additionally, Wegovy may reduce food cravings by modulating reward pathways in the brain's appetite centres. Unlike stimulant-based weight loss medications, Wegovy works through natural hormonal pathways, supporting gradual, sustainable weight management alongside a reduced-calorie diet and increased physical activity.
EverydayMeds Wegovy Ordering Process
Our streamlined ordering system begins with a comprehensive 3-minute online clinical assessment covering your medical history, current medications, and weight management goals. Our qualified prescribers review your assessment within 3 working days (or 24 hours with express service), ensuring Wegovy is clinically appropriate for your situation. Once approved, your prescription-only medicine is dispensed from our GPhC #9012878 registered pharmacy and dispatched via next-day delivery in temperature-controlled packaging. Our cold-chain logistics maintain the 2-8°C storage requirement throughout transit, ensuring your medication arrives in optimal condition. Clinical support continues post-dispatch with our pharmacy team available for dosing questions and practical guidance.
Wegovy Storage & Administration Practicalities
Wegovy arrives as a pre-filled FlexTouch pen requiring refrigerated storage between 2-8°C until first use. Once removed from refrigeration, the pen maintains potency for 6 weeks at room temperature below 30°C - significantly longer than competing medications. This storage flexibility proves invaluable for business travel, holidays, or temporary accommodation without reliable refrigeration. Each pen delivers one weekly subcutaneous injection, typically into the abdomen, thigh, or upper arm. The dose escalation schedule is mandatory, starting with 0.25mg for weeks 1-4, progressing through 0.5mg, 1mg, 1.7mg, to reach the 2.4mg maintenance dose by week 17, ensuring optimal tolerability whilst minimising gastrointestinal side effects.
Switching from Mounjaro to Wegovy: Dose Conversion Guide
Transitioning from tirzepatide (Mounjaro) to semaglutide (Wegovy) requires careful dose conversion due to different potency profiles. Patients established on Mounjaro 2.5mg may transition to Wegovy 1mg, whilst those on Mounjaro 5mg typically convert to Wegovy 1.7mg or 2.4mg depending on tolerability and response. The switch should occur at your next scheduled injection day, with your prescriber providing specific transition guidance. Unlike same-molecule switches, this cross-medication change may require temporary dose reduction to assess tolerability differences.
EverydayMeds stocks both medications, eliminating supply chain disruption during your transition period. Our clinical team coordinates with your prescriber to ensure seamless switching, maintaining treatment continuity without gaps. Many patients report improved gastrointestinal tolerance when switching from Mounjaro to Wegovy, though individual responses vary considerably. We recommend having both medications available during the transition week to accommodate any necessary adjustments your prescriber might recommend.
Complete Your Wegovy Switch Today
Ready to make the switch to Wegovy? Our clinical assessment takes just 3 minutes to complete, with prescriber review typically completed within 3 working days. New customers apply code FIRST40 at checkout for immediate savings, whilst returning customers use DOSE25. Visit https://everydaymeds.co.uk/collections/weight-loss to begin your assessment and secure your Wegovy supply from our GPhC #9012878 registered pharmacy. Our team supports your transition every step of the way, ensuring your weight management journey continues uninterrupted with proven cardiovascular benefits.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
